HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Ullmann Wealth Partners Group LLC

Ullmann Wealth Partners Group LLC lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.6% during the 4th quarter, Holdings Channel.com reports. The fund owned 6,802 shares of the company’s stock after selling 42 shares during the period. Ullmann Wealth Partners Group LLC’s holdings in HCA Healthcare were worth $2,042,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. American Century Companies Inc. boosted its stake in shares of HCA Healthcare by 60.0% in the second quarter. American Century Companies Inc. now owns 23,024 shares of the company’s stock valued at $7,397,000 after buying an additional 8,633 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of HCA Healthcare by 2.3% during the second quarter. Dimensional Fund Advisors LP now owns 520,835 shares of the company’s stock valued at $167,426,000 after buying an additional 11,861 shares during the period. Renaissance Technologies LLC acquired a new position in HCA Healthcare in the second quarter valued at $4,112,000. Mercer Global Advisors Inc. ADV grew its holdings in HCA Healthcare by 6.4% in the second quarter. Mercer Global Advisors Inc. ADV now owns 87,444 shares of the company’s stock valued at $28,064,000 after purchasing an additional 5,246 shares during the period. Finally, Blair William & Co. IL increased its holdings in shares of HCA Healthcare by 11.8% during the 2nd quarter. Blair William & Co. IL now owns 9,464 shares of the company’s stock worth $3,041,000 after buying an additional 998 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 1.0 %

Shares of NYSE:HCA opened at $309.26 on Friday. HCA Healthcare, Inc. has a 52-week low of $276.50 and a 52-week high of $417.14. The company has a 50-day simple moving average of $318.49 and a 200 day simple moving average of $353.11. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The company has a market capitalization of $78.34 billion, a P/E ratio of 13.89, a price-to-earnings-growth ratio of 1.03 and a beta of 1.64.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were given a dividend of $0.66 per share. The ex-dividend date was Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.85%. HCA Healthcare’s payout ratio is presently 11.85%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HCA. Barclays lowered their price target on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a report on Friday, November 8th. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price objective for the company from $400.00 to $320.00 in a report on Monday, November 25th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Finally, JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $385.27.

Insider Buying and Selling

In other news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.70% of the stock is currently owned by company insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.